United Therapeutics Corporation - Strategy, SWOT and Corporate Finance Report

United Therapeutics Corporation - Strategy, SWOT and Corporate Finance Report

Summary

United Therapeutics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

United Therapeutics Corporation (United Therapeutics or 'the company') is a biotechnology company focused on the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions. The product portfolio of the company includes Remodulin injection; Tyvaso (treprostinil) inhalation solution; Adcirca (tadalafil) tablets; Unituxin (dinutuximab) injection, and Orenitram (treprostinil) extended release tablets. Its product candidates include monoclonal antibodies (mAbs), glycobiology antiviral agents, and cell-based therapies. United Therapeutics sells products through specialty pharmaceutical distributors in the US. United Therapeutics operates in Europe, Israel and the Middle East, Asia and South and Central America. The company is headquartered in Silver Spring, Maryland, the US.

• Detailed information on United Therapeutics Corporation required for business and competitor intelligence needs
• A study of the major internal and external factors affecting United Therapeutics Corporation in the form of a SWOT analysis
• An in-depth view of the business model of United Therapeutics Corporation including a breakdown and examination of key business segments
• Intelligence on United Therapeutics Corporation's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about United Therapeutics Corporation, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reaasons to Buy
• Gain understanding of United Therapeutics Corporation and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess United Therapeutics Corporation as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on United Therapeutics Corporation's business structure, strategy and prospects.